Fig. 1From: ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignanciesProgression-free survival after the initiation of PD-1/PDL-1 inhibitor therapy. Kaplan–Meier plots were shown for patients with a thoracic malignancy. ICI, immune checkpoint inhibitor; Rs671(−), ALDH2*1/*1 (n = 56), rs671(+); ALDH2*1/*2 or ALDH2*2/*2 (n = 49). p, p value for Gahan–Breslow–Wilcoxon testBack to article page